In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus
about
Famciclovir for treatment of herpesvirus infectionsCross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virusEvidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducksPenciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cellsInhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.Duck hepatitis B virus replication in primary bile duct epithelial cells.Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovirTreatment of chronic hepatitis B: new antiviral therapies.Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid.The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.Interaction between ganciclovir and foscarnet as inhibitors of duck hepatitis B virus replication in vitro.New antiviral agents.In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.Short synthesis and antiviral activity of acyclic phosphonic acid nucleoside analogues.Review: Present and future directions in the treatment of chronic hepatitis B infection.Famciclovir (FAMVIR).Acyclic nucleosides as antiviral compounds.New therapies for chronic hepatitis B.Hepatitis B virus and liver transplantation: concepts in antiviral prophylaxis.Review: hepatitis B and liver transplantation.Hepatitis B virus infection and liver transplantation.Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.Current status of anti-HBV chemotherapy.Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer.Retransplantation for precore mutant-related chronic hepatitis B infection: prolonged survival in a patient receiving sequential ganciclovir/famciclovir therapy.Glycosylated macromolecular conjugates of antiviral drugs with a polyaspartamide.In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance.Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective.Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.Inhibitory Effect of Penciclovir-Triphosphate on Duck Hepatitis B Virus Reverse Transcription
P2860
Q28293932-475FF601-2501-4C30-8252-053B6CAE199AQ28365198-C17D928F-0F7C-4325-9D69-AAAB201FEAC5Q28369077-9E4E7A86-A5F2-45F6-B47A-F9BE045CFC1BQ28378980-2273BCEE-6382-4279-B053-E38D592E5F78Q33689987-4FBF2463-C1FB-4BB1-8916-1FA61212DBBFQ33698569-656D906C-BE21-4788-BB52-1B012BEB7B3CQ33801322-FAB275A0-7351-4CAA-BD7B-FC3F98B79763Q33852986-F3F2887E-3181-4D98-9424-A2DD6E22C8A7Q33978482-4D3BD785-0D48-4CED-B55F-0E2D94867056Q33978910-C6501907-2B36-458B-BE13-AAEC66C5C1CFQ34027579-8F5921FC-5D5A-41D0-86A9-96B4F97062DAQ34299035-40B966C4-A7A6-4D06-95DF-34F0BA1967A6Q35112005-D904D523-62E8-49D6-B54B-FB9A8678BBFCQ35122451-77ACFAAA-76FA-491C-93FE-D4E97A8679D7Q35124345-62975F56-C4CB-41BA-A394-434A486CCE53Q36525651-4F2C1EA1-EC73-41C6-9151-4D706E4807A6Q39784993-92A06A1F-B637-4CA2-ACCE-02D38D15D7E7Q39883520-2DA3CDAB-1B0F-4132-8A66-CE03F36A3D65Q40866538-024BA4A1-391E-48A3-97A7-000A65E8A607Q40907587-FC28C929-57FE-40BA-8F74-48E87BD133E1Q41058515-33FE4EC8-3D38-4207-AFDB-E7BE30B0A98AQ41428184-CA3AB221-4467-43FC-80DC-D0DBCBB68CF2Q41428212-F6CD3CA0-62AC-4D21-B235-1C3F8152DE1DQ41463466-5DDB4391-0FD8-45AD-AA61-30DB2F73AFBCQ42581069-A9FDDE5B-AD09-4478-B481-1DABC1338241Q43536044-248F0D11-D4B1-460E-B32A-ABD0A83CBD31Q43850205-6EF6F46A-D9D8-4DEC-84E2-9921B8118C31Q44663940-EB3BDEED-80EF-48BA-80BE-CEC6CDCF1AE9Q44908755-86CB4EC7-0593-43DA-9F31-0E869BC4F2B6Q45204026-C493AD73-B69B-4E57-A14E-A0E0D3034DE3Q45745393-14D777A2-5415-4FEB-A176-757EE41D9D0FQ45751095-27EE3089-3466-48B4-A1E8-ED1D2835A1EEQ45759880-E96631C4-4E1C-4DB1-ACED-6E7DD33280BBQ59286616-5EA9B6CA-1C59-48B3-89D8-A90ABCEC0818
P2860
In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
In vitro antiviral activity of ...... against duck hepatitis B virus
@ast
In vitro antiviral activity of ...... against duck hepatitis B virus
@en
In vitro antiviral activity of ...... against duck hepatitis B virus
@nl
type
label
In vitro antiviral activity of ...... against duck hepatitis B virus
@ast
In vitro antiviral activity of ...... against duck hepatitis B virus
@en
In vitro antiviral activity of ...... against duck hepatitis B virus
@nl
prefLabel
In vitro antiviral activity of ...... against duck hepatitis B virus
@ast
In vitro antiviral activity of ...... against duck hepatitis B virus
@en
In vitro antiviral activity of ...... against duck hepatitis B virus
@nl
P2093
P2860
P356
P1476
In vitro antiviral activity of ...... against duck hepatitis B virus
@en
P2093
P2860
P304
P356
10.1128/AAC.38.4.719
P407
P577
1994-04-01T00:00:00Z